MeoBan.gif (3289 bytes)

KU-W MedEd Home

Med Ed Synopsis of AHA material

Material at AHA WWW site

Heparin Guide (full text)

Tables
1. Antihemostatic effects of heparin
2. Heterogenicity of heparin
3. Methods of administration and dosage of heparin
4. Thrombotic risk of failure to achieve adequate aPTT
5. Heparin administration protocol example
6. Limitations of heparin
7. Clinical use of heparin
8. Complication and thromboembolic recurrence rates
9. Long vs. short-term heparin treatment of DVT
10. Efficacy of low-dose heparin vs. control
11. Bleeding complications of low-dose heparin vs. control
12. Value of heparin treatment after hip replacement
13. Heparin associated bleeding following thrombolytic treatment for AMI
14. Comparison of unfractionated and low molecular weight heparins
15. Low molecular weight heparin vs. placebo in orthopedic patients

Figures
1. Inactivation of clotting enzymes by heparin
2. Sites of heparin action on coagulation cascade
3. Heparin binding to ATIII
4. Molecular weight distributions of unfractionated and low molecular weight heparins
5. Heparin binding by blood proteins
6. Plasma half-time vs. dosage
7. Heparin saccharide units and activity

KU-W MedEd Home